193 related articles for article (PubMed ID: 10791522)
1. Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation.
Frassoni F; Labopin M; Powles R; Mary JY; Arcese W; Bacigalupo A; Bunjes D; Gluckman E; Ruutu T; Schaefer UW; Sierra J; Vernant JP; Willemze R; de Witte T; Gorin NC
Lancet; 2000 Apr; 355(9213):1393-8. PubMed ID: 10791522
[TBL] [Abstract][Full Text] [Related]
2. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT).
Poiré X; Labopin M; Maertens J; Yakoub-Agha I; Blaise D; Ifrah N; Socié G; Gedde-Dhal T; Schaap N; Cornelissen JJ; Vigouroux S; Sanz J; Michaux L; Esteve J; Mohty M; Nagler A
J Hematol Oncol; 2017 Jan; 10(1):20. PubMed ID: 28100265
[TBL] [Abstract][Full Text] [Related]
4. Are patients with acute leukaemia, alive and well 2 years post bone marrow transplantation cured? A European survey. Acute Leukaemia Working Party of the European Group for Bone Marrow Transplantation (EBMT).
Frassoni F; Labopin M; Gluckman E; Prentice HG; Gahrton G; Mandelli F; Carella M; Herve P; Gratwohl A; Goldman J
Leukemia; 1994 Jun; 8(6):924-8. PubMed ID: 8207985
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients.
Ringdén O; Labopin M; Beelen DW; Volin L; Ehninger G; Finke J; Greinix HT; Kyrcz-Krzemien S; Bunjes D; Brinch L; Niederwieser D; Arnold R; Mohty M; Rocha V;
J Intern Med; 2012 Nov; 272(5):472-83. PubMed ID: 22519980
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Ringdén O; Labopin M; Frassoni F; Sanz G; Demeocq F; Prentice H; Cahn JY; Barbui T; Meloni G; Schaefer U; Reiffers J; Gorin N
Bone Marrow Transplant; 1999 Aug; 24(4):389-96. PubMed ID: 10467328
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic bone marrow transplantation for leukaemia in Europe. Report from the Working Party on Leukaemia, European Group for Bone Marrow Transplantation.
Lancet; 1988 Jun; 1(8599):1379-82. PubMed ID: 2898053
[TBL] [Abstract][Full Text] [Related]
8. Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors.
Schiller G; Feig SA; Territo M; Wolin M; Lill M; Belin T; Hunt L; Nimer S; Champlin R; Gajewski J
Br J Haematol; 1994 Sep; 88(1):72-8. PubMed ID: 7803259
[TBL] [Abstract][Full Text] [Related]
9. Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow Transplantation.
Gorin NC; Labopin M; Frassoni F; Milpied N; Attal M; Blaise D; Meloni G; Iori AP; Michallet M; Willemze R; Deconninck E; Harousseau JL; Polge E; Rocha V
J Clin Oncol; 2008 Jul; 26(19):3183-8. PubMed ID: 18506024
[TBL] [Abstract][Full Text] [Related]
10. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT).
Gorin NC; Labopin M; Fouillard L; Meloni G; Frassoni F; Iriondo A; Brunet Mauri S; Goldstone AH; Harousseau JL; Reiffers J; Esperou-Bourdeau H; Gluckman E
Bone Marrow Transplant; 1996 Jul; 18(1):111-7. PubMed ID: 8832003
[TBL] [Abstract][Full Text] [Related]
11. No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Cahn JY; Labopin M; Sierra J; Blaise D; Reiffers J; Ferrant A; Bergmann L; Visani G; Cornelissen J; De Witte T; Bosi A; Frassoni F; Gorin NC
Br J Haematol; 2000 Aug; 110(2):308-14. PubMed ID: 10971386
[TBL] [Abstract][Full Text] [Related]
12. Haploidentical family member transplants for patients with chronic myeloid leukaemia: a report of the Chronic Leukaemia Working Party of off European Group for Blood and Marrow Transplantation (EBMT).
Speiser DE; Hermans J; van Biezen A; Starobinski M; Jeannet M; Jacobsen N; Niederwieser D; Gratwohl A; Apperley JF
Bone Marrow Transplant; 1997 Jun; 19(12):1197-203. PubMed ID: 9208113
[TBL] [Abstract][Full Text] [Related]
13. Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis. Acute Leukaemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation (EBMT) and the International Marrow Unrelated Search and Transplant (IMUST) Study.
Ringdén O; Labopin M; Gluckman E; Hows JM; Bradley BA; Kolb HJ; Fouillard L; Jacobsen N; Vernant JP; Witz F; Harousseau JL; Gorin NC
Bone Marrow Transplant; 1997 May; 19(10):963-8. PubMed ID: 9169639
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic bone marrow transplantation for acute leukaemia: comparative outcomes for adults and children.
Weisdorf DJ; McGlave PB; Ramsay NK; Miller WJ; Nesbit ME; Woods WG; Goldman AI; Kim TH; Kersey JH
Br J Haematol; 1988 Jul; 69(3):351-8. PubMed ID: 3044439
[TBL] [Abstract][Full Text] [Related]
15. Relapse after allogeneic bone marrow transplantation for acute leukaemia: a survey by the E.B.M.T. of 117 cases.
Frassoni F; Barrett AJ; Grañena A; Ernst P; Garthon G; Kolb HJ; Prentice HG; Vernant JP; Zwaan FE; Gratwohl A
Br J Haematol; 1988 Nov; 70(3):317-20. PubMed ID: 3061443
[TBL] [Abstract][Full Text] [Related]
16. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
Carlens S; Ringdén O; Aschan J; Hägglund H; Ljungman P; Mattsson J; Remberger M
Clin Transplant; 1998 Apr; 12(2):84-92. PubMed ID: 9575394
[TBL] [Abstract][Full Text] [Related]
17. Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate- or High-Risk Acute Myeloid Leukemia in Complete Remission: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Malard F; Labopin M; Stuhler G; Bittenbring J; Ganser A; Tischer J; Michallet M; Kröger N; Schmid C; Huynh A; Hallek M; Savani BN; Mohty M; Nagler A
Biol Blood Marrow Transplant; 2017 Feb; 23(2):278-284. PubMed ID: 27816650
[TBL] [Abstract][Full Text] [Related]
18. The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation (EBMT).
Ringdén O; Hermans J; Labopin M; Apperley J; Gorin NC; Gratwohl A
Leuk Lymphoma; 1996 Dec; 24(1-2):71-9. PubMed ID: 9049963
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic bone marrow transplantation for leukemia in Europe: regional differences. Report from the Leukemia Working party of the European Group for Bone Marrow Transplantation.
Gratwohl A; Hermans J; Barrett AJ; Ernst P; Frassoni F; Gahrton G; Granena A; Kolb HJ; Prentice HG; Vernant JP
Bone Marrow Transplant; 1990 Mar; 5(3):159-65. PubMed ID: 2331536
[TBL] [Abstract][Full Text] [Related]
20. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Gratwohl A; Hermans J; Goldman JM; Arcese W; Carreras E; Devergie A; Frassoni F; Gahrton G; Kolb HJ; Niederwieser D; Ruutu T; Vernant JP; de Witte T; Apperley J
Lancet; 1998 Oct; 352(9134):1087-92. PubMed ID: 9798583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
